Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11659142 | 0.93 | TSHR (0.39) | TSHROPRM1ALDH1A1DNM1 | |
| SCHEMBL9620315 | 0.84 | TSHR (0.46) | TSHROPRM1ALDH1A1ADH1BADH1C | |
| SCHEMBL18638803 | 0.84 | MMP9 (0.35) | TSHRALDH1A1 | |
| SCHEMBL9445647 | 0.82 | TSHR (0.40) | TSHROPRM1ALDH1A1ADH1BADH1C | |
| SCHEMBL11705357 | 0.81 | TSHR (0.48) | TSHROPRM1ALDH1A1ADH1BADH1C | |
| SCHEMBL4303707 | 0.78 | TSHR (0.40) | TSHROPRM1ALDH1A1ADH1BADH1C | |
| SCHEMBL564664 | 0.77 | TSHR (0.42) | TSHROPRM1ALDH1A1ADH1BADH1C | |
| SCHEMBL1137386 | 0.77 | OPRM1 (0.43) | TSHROPRM1ALDH1A1SPHK1TP53 | |
| SCHEMBL19066475 | 0.77 | TSHR (0.36) | TSHRALDH1A1SPHK1FAAHDNM1 | |
| SCHEMBL21608634 | 0.77 | TSHR (0.36) | TSHRALDH1A1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7256317-B2 | subjecting olefin mixture to metathesis, separating olefins, dimerizing, derivatizing (via hydroformylation) after fractionation, then alkoxylating; | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-14 | — | — | US | disclosed |
| US-20040186325-A1 | subjecting olefin mixture to metathesis, separating olefins, dimerizing, derivatizing (via hydroformylation) after fractionation, then alkoxylating; | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-23 | — | — | US | disclosed |
| US-6737553-B1 | SUBJECTING A C4-OLEFIN MIXTURE TO METATHESIS, DIMERIZING, DERIVATIZING | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040186325-A1 | subjecting olefin mixture to metathesis, separating olefins, dimerizing, derivatizing (via hydroformylation) after fractionation, then alkoxylating; | OSTC, ADH1C, PHOSPHO1 | TSHR 3588/4885OPRM1 670/4885ALDH1A1 609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.